Ghanem A, Shuler M L
School of Chemical Engineering, Cornell University, Ithaca, New York 14853-5201, USA.
Biotechnol Prog. 2000 May-Jun;16(3):334-45. doi: 10.1021/bp9901522.
An alternative method of evaluating the toxicology of a chemical is to use cultured mammalian cells in a novel cell culture analogue reactor (CCA) together with a corresponding physiologically based pharmacokinetic model (PBPK). The PBPK is a mathematical model that divides the body into compartments representing organs, integrating the kinetic, thermodynamic, and anatomical parameters of the animal. The bioreactor is a physical replica of the PBPK; where the PBPK specifies an organ or tissue compartment, the bioreactor contains compartments with a corresponding cell type. The device is a continuous, dynamic system composed of multiple cell types that interact through a common circulating cell culture medium. The bioreactor and the model are coupled to evaluate the plausibility of the molecular mechanism that is input into the model. This concept is tested with naphthalene as a model of PAH (polycyclic aromatic hydrocarbons) toxicants. Two physically different CCA reactors were tested with naphthalene, and different results were observed. In the prototype system using cells attached to glass dilution bottles, naphthalene dosing resulted in generation of a circulating metabolite from the "liver" compartment (based on H4IIE cells from a rat hepatoma) that caused cell death in the "lung" compartment (L2 cells from a rat lung), as well as depletion of glutathione in the L2 cells. An improved CCA using packed bed reactors of microcarrier cultured cells did not show differences between naphthalene-dosed and nondosed controls. To explain the different responses of the two CCA designs, PBPKs of the two reactors were tested with variations in physical and kinetic parameters, and toxic mechanism. When the toxic metabolite of naphthalene was naphthoquinone rather than naphthalene epoxide as initially assumed, the PBPK results were consistent with the results of the two CCA designs. This result indicates that the mechanism of naphthalene toxicity in the CCAs may be mediated through naphthoquinone formation. The CCA-PBPK concept is demonstrated to be applicable to the study of toxic mechanisms. In particular, use of this approach suggests that in vitro naphthalene toxicity is mediated through the naphthoquinone metabolite.
评估化学品毒理学的另一种方法是,在新型细胞培养模拟反应器(CCA)中使用培养的哺乳动物细胞,并结合相应的基于生理学的药代动力学模型(PBPK)。PBPK是一种数学模型,它将身体划分为代表器官的隔室,整合了动物的动力学、热力学和解剖学参数。生物反应器是PBPK的物理复制品;在PBPK指定器官或组织隔室的地方,生物反应器包含具有相应细胞类型的隔室。该装置是一个连续的动态系统,由多种细胞类型组成,这些细胞通过共同的循环细胞培养基相互作用。生物反应器和模型相互耦合,以评估输入模型的分子机制的合理性。以萘作为多环芳烃(PAH)毒物的模型对这一概念进行了测试。用萘对两个物理结构不同的CCA反应器进行了测试,观察到了不同的结果。在使用附着于玻璃稀释瓶的细胞的原型系统中,萘给药导致“肝脏”隔室(基于大鼠肝癌的H4IIE细胞)产生一种循环代谢物,该代谢物导致“肺”隔室(大鼠肺的L2细胞)中的细胞死亡,以及L2细胞中谷胱甘肽的消耗。使用微载体培养细胞的填充床反应器的改进型CCA在萘给药组和未给药对照组之间未显示出差异。为了解释两种CCA设计的不同反应,对两个反应器的PBPK进行了物理和动力学参数以及毒理机制变化的测试。当萘的有毒代谢物是萘醌而不是最初假设的萘环氧化物时,PBPK结果与两种CCA设计的结果一致。这一结果表明,CCA中萘的毒性机制可能是通过萘醌的形成介导的。CCA - PBPK概念被证明适用于毒理机制的研究。特别是,这种方法的使用表明体外萘毒性是通过萘醌代谢物介导的。